A study of a few patients, to be presented this week, showed promise for a type of therapy that has already cured some blood ...
A new injectable form of a key cancer drug could see thousands of NHS patients across the UK spending far less time in ...
Novel procedure combines image-guided tumor cryolysis with intratumoral immunotherapy infusion, with early clinical findings in metastatic prostate cancer ...
From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...
DENVER & SAN DIEGO--(BUSINESS WIRE)--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients ...
Tens of thousands of patients could benefit from a ‘rapid’ new immunotherapy jab on the NHS for over a dozen different cancers, which can be given in just 60 seconds.
French investigators are warning clinicians who treat patients with non–small cell lung cancer (NSCLC) not to initiate treatment with sotorasib within 30 days of an immunotherapy infusion with an anti ...
The Department of Health says it is "aware" of the jab and is "exploring" how it can be made available "as soon as possible".
Health minister hopes a key injectable cancer drug will be available in all five trusts "as soon as possible".
Some results have been hidden because they may be inaccessible to you
Show inaccessible results